Parasite

Antiparasitic compounds in Parasite act on malaria parasites, coccidia, other protozoa and parasitic worms. Parasites depend on enzymes, transporters and ion channels that differ from those of their hosts, which makes them useful subjects for comparative biochemistry. Antimalarial compounds include the cinchona alkaloid quinine and artemether, a methyl ether derivative of artemisinin that carries an endoperoxide bridge. Nitazoxanide is a thiazolide studied against both protozoa and helminths, and diclazuril is a triazine compound active against coccidia. The macrocyclic lactone doramectin belongs to the avermectin family, which acts on glutamate-gated chloride channels of nematodes and arthropods. Sulfonamides such as sulfadoxine and nitroimidazoles such as metronidazole extend the range of antiprotozoal classes.

5 Items

  • Quinacrine acetate
    Cat. No.
    A32209

    Quinacrine acetate

    Synonyms: Acriquine acetate

    Quinacrine acetate is a potent modulator of the cGAS-STING-TBK1 signaling pathway, exhibiting notable immune stimulatory activity. This compound has been investigated for its therapeutic potential in enhancing anti-tumor immunity and improving the efficacy of cancer immunotherapies by addressing the immunogenicity challenges faced by various tumors. Quinacrine acetate also represents a promising approach to mitigate the limitations associated with immune checkpoint inhibitors in cancer treatment.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PAM 1392
    Cat. No.
    A52550

    PAM 1392

    PAM 1392 is an anti-parasitic agent with demonstrated efficacy against Plasmodium berghei in murine models, as well as P. cynomolgi and P. knowlesi in non-human primates. Additionally, it exhibits significant anti-Trypanosoma cruzi activity in murine tissue cultures and acts against hemolytic streptococci in vitro. The dual antimalarial and antitrypanosomal properties of PAM 1392 make it a valuable compound for research focused on drug-resistant malaria and related parasitic diseases.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • TCMDC-136230
    Cat. No.
    A52638

    TCMDC-136230

    TCMDC-136230 is a novel modulator of calcium dynamics in malaria parasites. It effectively disrupts calcium regulation while showing minimal inhibition of heme crystallization. This compound is valuable for research focused on developing new antiparasitic therapies and understanding the molecular mechanisms underlying malaria pathogenesis.

    Out of stock

    All 3 sizes
  • TCMDC-125457
    Cat. No.
    A52654

    TCMDC-125457

    TCMDC-125457 is a potent parasite modulator that induces calcium redistribution while minimally inhibiting heme crystallization. This compound has shown high efficacy in a single-dose combination with artesunate, particularly against tightly synchronized artemisinin-resistant ring-stage parasites. Its unique mechanism and activity position TCMDC-125457 as a valuable tool for research into antimalarial therapies and the understanding of drug resistance in parasitic infections.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • TCMDC-125431
    Cat. No.
    A52826

    TCMDC-125431

    TCMDC-125431 is a novel modulator of parasite calcium dynamics, primarily targeting the malaria parasite. It effectively disrupts the regulatory mechanisms of calcium signaling while showing minimal inhibition of heme crystallization. This compound holds potential for research applications in understanding malaria pathophysiology and identifying new therapeutic strategies against malaria.

    Out of stock

    All 3 sizes

5 Items

Added to your cart

View Cart Checkout

    Loading...